Get the Stockscreener App
12.69
1.44%
0.18
After Hours:
12.70
0.010
+0.08%
Delcath Systems Inc stock is traded at $12.69, with a volume of 372.80K.
It is up +1.44% in the last 24 hours and down -21.08% over the past month.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
See More
Previous Close:
$12.51
Open:
$12.65
24h Volume:
372.80K
Relative Volume:
0.77
Market Cap:
$555.83M
Revenue:
$2.07M
Net Income/Loss:
$-47.68M
P/E Ratio:
-4.50
EPS:
-2.82
Net Cash Flow:
$-31.31M
1W Performance:
-9.68%
1M Performance:
-21.08%
6M Performance:
+0.16%
1Y Performance:
+60.43%
1-Day Range:
$12.43
$12.90
1-Week Range:
$12.43
$14.15
52-Week Range:
$7.1701
$18.23
Delcath Systems Inc Stock (DCTH) Company Profile
Name
Delcath Systems Inc
Sector
Industry
Phone
(518) 743-8892
Address
566 QUEENSBURY AVENUE, QUEENSBURY, NY
Compare DCTH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DCTH
Delcath Systems Inc
|
12.69 | 555.83M | 2.07M | -47.68M | -31.31M | -2.82 |
|
ABT
Abbott Laboratories
|
134.44 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.32 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
395.28 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
88.39 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.79 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Delcath Systems Inc Stock (DCTH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-28-24 | Initiated | Craig Hallum | Buy |
| May-14-24 | Initiated | Stephens | Overweight |
| Jul-26-22 | Resumed | Canaccord Genuity | Buy |
| Dec-10-21 | Initiated | H.C. Wainwright | Buy |
| Mar-09-21 | Initiated | Canaccord Genuity | Buy |
| Jan-05-21 | Initiated | BTIG Research | Buy |
| Jun-01-20 | Initiated | Laidlaw | Buy |
View All
Delcath Systems Inc Stock (DCTH) Latest News
(DCTH) Technical Data - news.stocktradersdaily.com
Bank of America Corp DE Purchases 24,359 Shares of Delcath Systems, Inc. (NASDAQ:DCTH) - Defense World
Delcath Systems Inc (DCTH) Shares Gap Down to $15.35 on Jun 12 - GuruFocus
Delcath Systems: Growing Fast, But Business Model Is Fragile (NASDAQ:DCTH) - Seeking Alpha
DCTH to Participate in Upcoming Virtual Meeting Hosted by Stephe - GuruFocus
DCTH to Participate in Upcoming Virtual Meeting Hosted by Stephens | DCTH Stock News - GuruFocus
NBC Securities Inc. Buys 9,990 Shares of Delcath Systems, Inc. (NASDAQ:DCTH) - Defense World
How to Take Advantage of moves in (DCTH) - news.stocktradersdaily.com
Delcath Systems, Inc. (DCTH) Is Up 0.62% in One Week: What You Should Know - Yahoo Finance
Is Benitec Biopharma (BNTC) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Wall Street Zen Downgrades Delcath Systems (NASDAQ:DCTH) to Buy - Defense World
Millennium Management LLC Increases Holdings in Delcath Systems, Inc. (NASDAQ:DCTH) - Defense World
Delcath Systems Inc (DCTH) Trading Down 7.33% on May 30 - GuruFocus
Northern Trust Corp Purchases 36,643 Shares of Delcath Systems, Inc. (NASDAQ:DCTH) - Defense World
Paragon 28 (NYSE:FNA) vs. Delcath Systems (NASDAQ:DCTH) Critical Survey - Defense World
Wall Street Analysts Predict a 48.69% Upside in Delcath Systems (DCTH): Here's What You Should Know - sharewise
Here's Why Momentum in Delcath Systems (DCTH) Should Keep going - Yahoo Finance
Learn to Evaluate (DCTH) using the Charts - news.stocktradersdaily.com
Analysts Set Expectations for Delcath Systems Q1 Earnings - Defense World
HC Wainwright Reaffirms “Buy” Rating for Delcath Systems (NASDAQ:DCTH) - Defense World
Delcath sets outlook amid plans to enter National Medicaid Drug Rebate Agreement - MSN
H.C. Wainwright Boosts Delcath Systems (DCTH) Price Target Amid Strategic Moves | DCTH Stock News - GuruFocus
Delcath Systems (NASDAQ:DCTH) Rating Increased to Strong-Buy at Wall Street Zen - Defense World
Delcath Systems rises after Wainwright PT raise - TradingView
Tesla To Rally Around 47%? Here Are 10 Top Analyst Forecasts For Friday - Benzinga
Delcath Systems (DCTH): HC Wainwright & Co. Raises Price Target - GuruFocus
Delcath Systems eyes USD 94-98 M revenue in FY 2025 - Medical Buyer
Delcath Systems Inc (DCTH) Shares Gap Down to $16.63 on May 22 - GuruFocus
Delcath forecasts $94-98 million in 2025 revenue, plans Medicaid deal - Investing.com Australia
Delcath forecasts $94-98 million in 2025 revenue, plans Medicaid deal By Investing.com - Investing.com South Africa
Delcath Systems, Inc.'s (NASDAQ:DCTH) 52% Jump Shows Its Popularity With Investors - simplywall.st
Delcath Systems Provides Full-Year Revenue Guidance; Shares Rise - marketscreener.com
Delcath Systems (DCTH) Projects Strong Financial Performance for 2025 | DCTH Stock News - GuruFocus
Delcath Systems (DCTH) Projects Significant Revenue Growth with New Medicaid Agreement - GuruFocus
Delcath Systems (DCTH) Unveils 2025 Financial Guidance and Medic - GuruFocus
Delcath Systems Announces 2025 Financial Guidance - TipRanks
Delcath Systems (DCTH) Unveils 2025 Financial Guidance and Medicaid Expansion Plan | DCTH Stock News - GuruFocus
Delcath stock gains after setting 2025 outlook (DCTH:NASDAQ) - Seeking Alpha
Delcath Systems Targets Positive Adj. EBITDA In Each Quarter Of 2025 - Nasdaq
Delcath Systems to Participate at the H.C. Wainwright 25th Annual Investor Conference on September 12 and 13, 2023 - The Globe and Mail
Uveal Melanoma Treatment Market Growth Analysis, Emerging Trends, and Future Opportunities to 2031 - openPR.com
DCTH stock soars to 52-week high, reaching $17.17 By Investing.com - Investing.com South Africa
DCTH stock soars to 52-week high, reaching $17.17 - Investing.com Australia
Delcath Systems: Q1 Earnings Show A Growth Spurt And Switch To Execution (DCTH) - Seeking Alpha
Delcath Systems, Inc. (NASDAQ:DCTH) Shares Bought by Jane Street Group LLC - Defense World
Delcath Systems Inc (DCTH) Trading 3.99% Higher on May 16 - GuruFocus
Delcath Systems Shareholders Approve Key Amendments at Meeting - TipRanks
Delcath Systems to Participate at the Craig-Hallum 22nd Annual Investor Conference | DCTH Stock News - GuruFocus
Delcath Systems to Participate at the Craig-Hallum 22nd Annual Investor Conference - BioSpace
Delcath Systems Inc Stock (DCTH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Delcath Systems Inc Stock (DCTH) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| MICHEL GERARD J | CHIEF EXECUTIVE OFFICER |
Oct 22 '24 |
Option Exercise |
6.00 |
16,666 |
99,996 |
319,334 |
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):